Bleeding and safety outcomes in persons with haemophilia A without inhibitors: Results from a prospective non‐interventional study in a real‐world setting-Reference-Cited by-同舟云学术

Bleeding and safety outcomes in persons with haemophilia A without inhibitors: Results from a prospective non‐interventional study in a real‐world setting

Published:2019-02-06 Issue:2 Volume:25 Page:213-220
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:Haemophilia

Author:

Kruse‐Jarres Rebecca¹^ORCID,Oldenburg Johannes²^ORCID,Santagostino Elena³,Shima Midori⁴,Kempton Christine L.⁵^ORCID,Kessler Craig M.⁶,Lehle Michaela⁷,Chebon Sammy⁷,Selak Bienz Nives⁷,Asikanius Elina⁷,Mahlangu Johnny⁸^ORCID

Affiliation:

1. Washington Center for Bleeding Disorders at Bloodworks Northwest Seattle Washington

2. Universitätsklinikum Bonn Bonn Germany

3. Centro Emofilia e Trombosi A. Bianchi Bonomi IRCCS Fondazione Ca' Granda Milano Italy

4. Department of Pediatrics Nara Medical University Kashihara Japan

5. Department of Hematology and Medical Oncology Emory School of Medicine Atlanta Georgia

6. Lombardi Comprehensive Cancer Center Georgetown University Medical Center Washington District of Columbia

7. F. Hoffmann‐La Roche Ltd Basel Switzerland

8. Haemophilia Comprehensive Care Centre, Faculty of Health Sciences University of the Witwatersrand and NHLS Parktown, Johannesburg South Africa

Funder

Roche

Publisher

Wiley

Subject

Genetics(clinical),Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hae.13655

Reference23 articles.

1. The Hemophilias — From Royal Genes to Gene Therapy

3. Longitudinal Changes in Health-Related Quality of Life for Chronic Diseases: An Example in Hemophilia A

4. Recombinant factor VIII in the management of hemophilia A: current use and future promise

5. The current status of prophylactic replacement therapy in children and adults with haemophilia

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Disease and treatment burden of patients with haemophilia entering the explorer6 non‐interventional study;European Journal of Haematology;2024-07-19

2. Fitusiran prophylaxis in people with hemophilia A or B who switched from prior BPA/CFC prophylaxis: the ATLAS-PPX trial;Blood;2024-05-30

3. Long-term outcomes with emicizumab in hemophilia A without inhibitors: results from the HAVEN 3 and 4 studies;Research and Practice in Thrombosis and Haemostasis;2024-02

4. Interim analyses of the multinational real‐world prospective cohort HEM‐POWR study evaluating the effectiveness and safety of damoctocog alfa pegol in patients with hemophilia A;European Journal of Haematology;2023-10-24

5. Unmet needs for severe hemophilia A cases without inhibitors in Argentina: a cross-sectional study.;Revista Hematología;2023-09-28